You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Claudia A. Salinas; Ilir Agalliu; Janet L. Stanford; Daniel W. Lin
JAMA 2006; 295: 2721.
[Extract][Full text][PDF]
Original Contributions Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
Victor G. Vogel; Joseph P. Costantino; D. Lawrence Wickerham; Walter M. Cronin; Reena S. Cecchini; James N. Atkins; Therese B. Bevers; Louis Fehrenbacher; Eduardo R. Pajon Jr; James L. Wade III; André Robidoux; Richard G. Margolese; Joan James; Scott M. Lippman; Carolyn D. Runowicz; Patricia A. Ganz; Steven E. Reis; Worta McCaskill-Stevens; Leslie G. Ford; V. Craig Jordan; Norman Wolmark; for the National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA 2006; 295: 2727-2741.
[Abstract][Full text][PDF][ Author in the Room Audio ]
Original Contributions Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial
Stephanie R. Land; D. Lawrence Wickerham; Joseph P. Costantino; Marcie W. Ritter; Victor G. Vogel; Myoungkeun Lee; Eduardo R. Pajon; James L. Wade III; Shaker Dakhil; James B. Lockhart Jr; Norman Wolmark; Patricia A. Ganz
JAMA 2006; 295: 2742-2751.
[Abstract][Full text][PDF]
Editorials Selective Estrogen Receptor Modulators and Prevention of Invasive Breast Cancer
